Search - tctmd.com

Displaying 401 - 420 of 2037

Sort: Relevancy | Date

Mavacamten Slashes Need for Septal Reduction in Obstructive HCM: VALOR-HCM

News Conference News ACC 2022

Mavacamten Slashes Need for Septal Reduction in Obstructive HCM: VALOR-HCM

Yael L. Maxwell

April 02, 2022

Prognosis of Myocarditis Following COVID-19 Vaccination ‘Favorable’

News Daily News

Prognosis of Myocarditis Following COVID-19 Vaccination ‘Favorable’

Michael O'Riordan

March 28, 2022

Deep-Learning Tool Can Gauge Plaque Burden, Stenosis Severity on CCTA

News Daily News

Deep-Learning Tool Can Gauge Plaque Burden, Stenosis Severity on CCTA

Yael L. Maxwell

March 28, 2022

Nitroglycerin Given Early or Late Fails to Prevent Radial Artery Occlusion: PATENS

News Conference News ACC 2022

Nitroglycerin Given Early or Late Fails to Prevent Radial Artery Occlusion: PATENS

Michael O'Riordan

March 25, 2022

Can a Smartphone App Use Voice Patterns to Predict CAD Events?

News Conference News ACC 2022

Can a Smartphone App Use Voice Patterns to Predict CAD Events?

March 24, 2022

Empagliflozin Plus an MRA Is Safe in HFpEF, May Help With Hyperkalemia

News Daily News

Empagliflozin Plus an MRA Is Safe in HFpEF, May Help With Hyperkalemia

March 22, 2022

Thorsten Stender, Cardiovascular Technologist

News CV Team Pro

Thorsten Stender, Cardiovascular Technologist

March 15, 2022

Many COVID-19 Patients Do Well 1 Year After VV-ECMO

News Daily News

Many COVID-19 Patients Do Well 1 Year After VV-ECMO

March 11, 2022

Thrombolysis ‘Safe and Effective’ for Obstructive Mechanical Valve Thrombosis

News Daily News

Thrombolysis ‘Safe and Effective’ for Obstructive Mechanical Valve Thrombosis

Yael L. Maxwell

March 09, 2022

Ross Procedure Again Surpasses Bioprosthetic AVR: Toronto Experience

News Daily News

Ross Procedure Again Surpasses Bioprosthetic AVR: Toronto Experience

March 08, 2022

Strength Training Linked to Less Premature Mortality, CVD, and Diabetes

News Daily News

Strength Training Linked to Less Premature Mortality, CVD, and Diabetes

Michael O'Riordan

March 02, 2022

Longer-Term LRT Results ‘Encouraging’ for TAVI in Low-risk Patients

News Conference News

Longer-Term LRT Results ‘Encouraging’ for TAVI in Low-risk Patients

March 01, 2022

Financial Strain Ups Risk of Death After Acute MI in the Elderly

News Daily News

Financial Strain Ups Risk of Death After Acute MI in the Elderly

February 25, 2022

Tenecteplase Feasible Up to 24 Hours After Stroke

News Conference News ISC 2022

Tenecteplase Feasible Up to 24 Hours After Stroke

February 15, 2022

CHOICE: Intra-arterial tPA Enhances Benefit of Stroke Thrombectomy

News Conference News ISC 2022

CHOICE: Intra-arterial tPA Enhances Benefit of Stroke Thrombectomy

February 11, 2022

Probe Beyond Ejection Fraction to Understand and Manage HFpEF

News Conference News THT 2022

Probe Beyond Ejection Fraction to Understand and Manage HFpEF

February 07, 2022

Higher Mortality After MV Surgery in Poorer Communities: STS Database

News Conference News STS 2022

Higher Mortality After MV Surgery in Poorer Communities: STS Database

Michael O'Riordan

February 02, 2022

Transcatheter Mitral Valve-in-Valve a ‘Good Option’, but With Higher Gradients

News Conference News STS 2022

Transcatheter Mitral Valve-in-Valve a ‘Good Option’, but With Higher Gradients

February 02, 2022

Invasive Cardiomechanics During Transcatheter Edge-to-Edge Repair for Massive Tricuspid Regurgitation Using Biventricular Pressure-Volume Loop Monitoring

Presentation THT 2022

Invasive Cardiomechanics During Transcatheter Edge-to-Edge Repair for Massive Tricuspid Regurgitation Using Biventricular Pressure-Volume Loop Monitoring

Presenter: Antoon van den Enden

February 02, 2022

Changes in Voice Patterns for Monitoring Volume Status (Cardio)

Presentation THT 2022

Changes in Voice Patterns for Monitoring Volume Status (Cardio)

Presenter: Chaim Lotan

February 01, 2022

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.